e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The "rapid decliner" COPD phenotype
I. Cerveri, A. G. Corsico, R. Niniano, V. Ronzoni, R. Cavalli, A. Grosso, A. Foresi, F. Imberti, T. Galasso, E. Tsana Tegomo, E. Pozzi (Pavia, Italy)
Source:
Annual Congress 2010 - COPD: diagnosis
Session:
COPD: diagnosis
Session type:
Thematic Poster Session
Number:
4037
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Cerveri, A. G. Corsico, R. Niniano, V. Ronzoni, R. Cavalli, A. Grosso, A. Foresi, F. Imberti, T. Galasso, E. Tsana Tegomo, E. Pozzi (Pavia, Italy). The "rapid decliner" COPD phenotype. Eur Respir J 2010; 36: Suppl. 54, 4037
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The "rapid decliner" as a COPD phenotype associated with predominant emphysema
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
The "susceptibility to exacerbation" phenotype in COPD and response to pulmonary rehabilitation
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011
Imbalances in TNFα in patients with a TNFα polymorphism and a COPD phenotype
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Helicobacter pylori
infection in COPD
Source: Annual Congress 2010 - Various aspects of respiratory epidemiology
Year: 2010
COPD phenotypes
Source: International Congress 2015 – PG2 Asthma and COPD
Year: 2015
COPD phenotypes
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016
Hedgehog-interacting protein
(
HHIP
) polymorphisms and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011
Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Does SpO
2
correlate with SaO
2
in stable COPD patients?
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012
GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Are there any differences between Tunisian and European COPD phenotypes?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
CAT in COPD phenotypes (POPE study)
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Predictors of PAO
2
and PaCO
2
in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Significance of quantitative radiological phenotypes of COPD on BODE index
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
A proposal of COPD phenotypes
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012
Effect of ivacaftor on lung clearance index and FEV
1
in subjects with CF who have the
G551D-CFTR
mutation and mild lung disease
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new therapies and detection of early lung disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept